Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
30 May 2024
| 23:37 | Post-transplant lymphoproliferative disorder diffhist +21 Warner-admin talk contribs | ||||
| 23:37 | Acute myeloid leukemia - historical diffhist +55 Warner-admin talk contribs | ||||
|
|
23:22 | Diffuse large B-cell lymphoma 2 changes history +209 [Warner-admin; Jwarner] | |||
|
|
23:22 (cur | prev) +9 Warner-admin talk contribs | ||||
| m |
|
14:13 (cur | prev) +200 Jwarner talk contribs | |||
| m 17:36 | CNS lymphoma diffhist +3,516 Jwarner talk contribs →Methotrexate-Cytarabine {{#subobject:f24bde|Regimen=1}} | ||||
25 May 2024
|
|
m 12:43 | Non-small cell lung cancer 5 changes history +9,453 [Jwarner (5×)] | |||
| m |
|
12:43 (cur | prev) 0 Jwarner talk contribs | |||
| m |
|
12:42 (cur | prev) +88 Jwarner talk contribs | |||
| m |
|
12:42 (cur | prev) +1,891 Jwarner talk contribs →Carboplatin & Pemetrexed {{#subobject:920f46|Regimen=1}} | |||
| m |
|
12:37 (cur | prev) +1,267 Jwarner talk contribs →Pembrolizumab monotherapy {{#subobject:430dc7|Regimen=1}} | |||
| m |
|
12:28 (cur | prev) +6,207 Jwarner talk contribs →Carboplatin & Paclitaxel (CP) {{#subobject:c5fbdf|Regimen=1}} | |||
| m 02:27 | Diffuse large B-cell lymphoma diffhist +180 Jwarner talk contribs | ||||
24 May 2024
|
|
m 01:04 | Melanoma 3 changes history +1,697 [Jwarner (3×)] | |||
| m |
|
01:04 (cur | prev) -83 Jwarner talk contribs →Pembrolizumab monotherapy {{#subobject:0a3e71|Regimen=1}} | |||
| m |
|
01:04 (cur | prev) +499 Jwarner talk contribs →Neoadjuvant immunotherapy | |||
| m |
|
00:58 (cur | prev) +1,281 Jwarner talk contribs →Pembrolizumab monotherapy {{#subobject:0a3e71|Regimen=1}} | |||
23 May 2024
| m 17:21 | Post-transplant lymphoproliferative disorder diffhist +829 Jwarner talk contribs →Tabelecleucel monotherapy {{#subobject:32c6a1|Regimen=1}} | ||||
19 May 2024
|
|
m 01:07 | Diffuse large B-cell lymphoma 2 changes history +66 [Jwarner (2×)] | |||
| m |
|
01:07 (cur | prev) +21 Jwarner talk contribs →R-ESHAP {{#subobject:7794d|Regimen=1}} | |||
| m |
|
01:05 (cur | prev) +45 Jwarner talk contribs →Regimen {{#subobject:b6038c|Variant=1}} | |||
18 May 2024
|
|
m 11:56 | HIV-associated lymphoma 2 changes history +269 [Jwarner (2×)] | |||
| m |
|
11:56 (cur | prev) +180 Jwarner talk contribs | |||
| m |
|
11:52 (cur | prev) +89 Jwarner talk contribs →CVP {{#subobject:1a817a|Regimen=1}} | |||
17 May 2024
| m 18:25 | Diffuse large B-cell lymphoma diffhist +468 Jwarner talk contribs →References | ||||
16 May 2024
| m 10:55 | Non-small cell lung cancer diffhist -80 Jwarner talk contribs →References | ||||
15 May 2024
| m 11:32 | Adult T-cell leukemia-lymphoma diffhist -7 Warner-admin talk contribs Text replacement - "*<big>We have moved How I Treat articles to a dedicated page.</big>" to "*''We have moved How I Treat articles to a dedicated page.''" | ||||
11 May 2024
| m 01:28 | Diffuse large B-cell lymphoma diffhist +443 Jwarner talk contribs →Mitoxantrone monotherapy {{#subobject:6e3e59|Regimen=1}} | ||||
10 May 2024
|
|
m 20:22 | Melanoma 3 changes history +1,906 [Jwarner (3×)] | |||
| m |
|
20:22 (cur | prev) +1,273 Jwarner talk contribs →Pembrolizumab monotherapy {{#subobject:0a3e71|Regimen=1}} | |||
| m |
|
20:19 (cur | prev) +2 Jwarner talk contribs →Pembrolizumab monotherapy {{#subobject:0a3e71|Regimen=1}} | |||
| m |
|
20:16 (cur | prev) +631 Jwarner talk contribs | |||
9 May 2024
| m 02:39 | Diffuse large B-cell lymphoma diffhist 0 Jwarner talk contribs →NCCN | ||||
|
|
m 02:37 | Adult T-cell leukemia-lymphoma 2 changes history +5 [Warner-admin (2×)] | |||
| m |
|
02:37 (cur | prev) -16 Warner-admin talk contribs Text replacement - "https://www.nccn.org/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1483" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1483" | |||
| m |
|
02:13 (cur | prev) +21 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/t-cell.pdf" to "https://www.nccn.org/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1483" | |||
7 May 2024
| m 11:21 | Non-small cell lung cancer diffhist +7 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1450" | ||||
| m 11:09 | Neuroblastoma diffhist +126 Jwarner talk contribs | ||||
|
|
m 00:01 | Melanoma 2 changes history +1 [Warner-admin; Jwarner] | |||
| m |
|
00:01 (cur | prev) -7 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/cutaneous_melanoma.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1492" | |||
| m |
|
00:01 (cur | prev) +8 Jwarner talk contribs →NCCN | |||
6 May 2024
| m 21:09 | Melanoma diffhist -20 Jwarner talk contribs →Pembrolizumab monotherapy {{#subobject:78ub8c|Regimen=1}} | ||||
| m 18:06 | CNS lymphoma diffhist +8 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1425" | ||||
|
|
m 14:55 | Non-small cell lung cancer 2 changes history +7 [Jwarner (2×)] | |||
| m |
|
14:55 (cur | prev) -1 Jwarner talk contribs →NCCN | |||
| m |
|
14:54 (cur | prev) +8 Jwarner talk contribs →NCCN | |||
| m 14:42 | Post-transplant lymphoproliferative disorder diffhist +5 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1480" | ||||
| m 14:42 | Burkitt lymphoma diffhist +5 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1480" | ||||
| m 14:42 | Diffuse large B-cell lymphoma diffhist +5 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1480" | ||||
| m 14:42 | HIV-associated lymphoma diffhist +5 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1480" | ||||
3 May 2024
|
|
m 20:46 | Small cell lung cancer - historical 2 changes history +806 [Jwarner (2×)] | |||
| m |
|
20:46 (cur | prev) +355 Jwarner talk contribs →ICE {{#subobject:f535c2|Regimen=1}} | |||
| m |
|
20:43 (cur | prev) +451 Jwarner talk contribs →CC/DE & RT {{#subobject:189bcc|Regimen=1}} | |||
| m 17:00 | HIV-associated lymphoma diffhist -24 Jwarner talk contribs →CNS therapy, prophylaxis {{#subobject:724xbj|Variant=1}} | ||||
| m 16:40 | Burkitt lymphoma diffhist -25 Jwarner talk contribs | ||||